{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,7]],"date-time":"2025-10-07T12:09:08Z","timestamp":1759838948733,"version":"3.37.3"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,11,16]],"date-time":"2024-11-16T00:00:00Z","timestamp":1731715200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,11,16]],"date-time":"2024-11-16T00:00:00Z","timestamp":1731715200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100005230","name":"Natural Science Foundation of Chongqing Municipality","doi-asserted-by":"publisher","award":["CSTB2024NSCQ-MSX0229"],"award-info":[{"award-number":["CSTB2024NSCQ-MSX0229"]}],"id":[{"id":"10.13039\/501100005230","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Breast Cancer"],"published-print":{"date-parts":[[2025,1]]},"DOI":"10.1007\/s12282-024-01646-7","type":"journal-article","created":{"date-parts":[[2024,11,16]],"date-time":"2024-11-16T15:09:12Z","timestamp":1731769752000},"page":"154-165","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Development and validation of a predictive risk tool for VTE in women with breast cancer under chemotherapy: a cohort study in China"],"prefix":"10.1007","volume":"32","author":[{"given":"Qianjie","family":"Xu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaosheng","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuliang","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zuhai","family":"Hu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guanzhong","family":"Liang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ying","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ya","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haike","family":"Lei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,11,16]]},"reference":[{"key":"1646_CR1","doi-asserted-by":"publisher","DOI":"10.3390\/cancers14102569","author":"B Smolarz","year":"2022","unstructured":"Smolarz B, Nowak AZ, Romanowicz H. Breast cancer-epidemiology, classification, pathogenesis and treatment (Review of Literature). Cancers. 2022. https:\/\/doi.org\/10.3390\/cancers14102569.","journal-title":"Cancers."},{"key":"1646_CR2","doi-asserted-by":"crossref","unstructured":"Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global cancer statistics 2020: globocan estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71(3):209\u201349.","DOI":"10.3322\/caac.21660"},{"issue":"1","key":"1646_CR3","doi-asserted-by":"publisher","first-page":"e12681","DOI":"10.1016\/j.heliyon.2022.e12681","volume":"9","author":"Q Xu","year":"2023","unstructured":"Xu Q, Lei H, Li X, Li F, Shi H, Wang G, et al. Machine learning predicts cancer-associated venous thromboembolism using clinically available variables in gastric cancer patients. Heliyon. 2023;9(1):e12681.","journal-title":"Heliyon"},{"issue":"4","key":"1646_CR4","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1007\/s12282-023-01452-7","volume":"30","author":"S Ohsumi","year":"2023","unstructured":"Ohsumi S, Watanabe K, Kondo N, Kosaka Y, Ishikawa T, Kitahara M, et al. Venous thromboembolism in Japanese patients with breast cancer: subgroup analysis of the Cancer-VTE Registry. Breast cancer (Tokyo, Japan). 2023;30(4):607\u201316.","journal-title":"Breast cancer (Tokyo, Japan)"},{"issue":"3","key":"1646_CR5","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1002\/cncr.30364","volume":"123","author":"JS Brand","year":"2017","unstructured":"Brand JS, Hedayati E, Bhoo-Pathy N, Bergh J, Hall P, Humphreys K, et al. Time-dependent risk and predictors of venous thromboembolism in breast cancer patients: A population-based cohort study. Cancer. 2017;123(3):468\u201375.","journal-title":"Cancer"},{"key":"1646_CR6","doi-asserted-by":"publisher","first-page":"100229","DOI":"10.1016\/j.clinsp.2023.100229","volume":"78","author":"JY Maesaka","year":"2023","unstructured":"Maesaka JY, Reis YN, Elias LM, Akerman D, Baracat EC, Filassi JR. Venous thromboembolism incidence in postoperative breast cancer patients. Clinics (Sao Paulo, Brazil). 2023;78:100229.","journal-title":"Clinics (Sao Paulo, Brazil)"},{"key":"1646_CR7","doi-asserted-by":"publisher","DOI":"10.3390\/cancers15123124","author":"JH Park","year":"2023","unstructured":"Park JH, Ahn SE, Kwon LM, Ko HH, Kim S, Suh YJ, et al. The Risk of venous thromboembolism in korean patients with breast cancer: a single-center experience. Cancers. 2023. https:\/\/doi.org\/10.3390\/cancers15123124.","journal-title":"Cancers."},{"issue":"3","key":"1646_CR8","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1177\/2292550320967397","volume":"29","author":"M Castaldi","year":"2021","unstructured":"Castaldi M, George G, Stoller C, Parsikia A, McNelis J. Independent predictors of venous thromboembolism in patients undergoing reconstructive breast cancer Surgery. Plastic Surg (Oakville, Ont). 2021;29(3):160\u20138.","journal-title":"Plastic Surg (Oakville, Ont)"},{"issue":"17","key":"1646_CR9","doi-asserted-by":"publisher","first-page":"2092","DOI":"10.1161\/CIRCULATIONAHA.111.084467","volume":"125","author":"MA Rogers","year":"2012","unstructured":"Rogers MA, Levine DA, Blumberg N, Flanders SA, Chopra V, Langa KM. Triggers of hospitalization for venous thromboembolism. Circulation. 2012;125(17):2092\u20139.","journal-title":"Circulation"},{"issue":"6","key":"1646_CR10","doi-asserted-by":"publisher","first-page":"2113","DOI":"10.31557\/APJCP.2022.23.6.2113","volume":"23","author":"K Jayasakoon","year":"2022","unstructured":"Jayasakoon K, Punyashthira A, Somboon B, Pattaraarchachai J, Suwannarurk K. Gynecologic malignancy-associated venous thromboembolism and predictive tool at Thammasat University Hospital. Asian Pac J Cancer Prev\u202f: APJCP. 2022;23(6):2113\u20138.","journal-title":"Asian Pac J Cancer Prev : APJCP"},{"issue":"10","key":"1646_CR11","doi-asserted-by":"publisher","first-page":"300060521105073","DOI":"10.1177\/03000605211050735","volume":"49","author":"C Liu","year":"2021","unstructured":"Liu C, Yi J, Jia J. Diagnostic and prognostic nomograms for bone metastasis in small cell lung cancer. J Int Med Res. 2021;49(10):3000605211050735.","journal-title":"J Int Med Res"},{"issue":"12","key":"1646_CR12","doi-asserted-by":"publisher","first-page":"3465","DOI":"10.1007\/s00277-023-05418-9","volume":"102","author":"X Li","year":"2023","unstructured":"Li X, Xu Q, Gao C, Yang Z, Li J, Sun A, et al. Development and validation of nomogram prognostic model for predicting OS in patients with diffuse large B-cell lymphoma: a cohort study in China. Ann Hematol. 2023;102(12):3465\u201375.","journal-title":"Ann Hematol"},{"key":"1646_CR13","doi-asserted-by":"publisher","first-page":"107602962312169","DOI":"10.1177\/10760296231216966","volume":"29","author":"Y Wu","year":"2023","unstructured":"Wu Y, Wang L, Yin Q, Deng L, Ma J, Tian X. establishment and validation of a postoperative VTE prediction model in patients with colorectal cancer undergoing radical resection: CRSPOT nomogram. Clin Appl Thromb\/Hemost\u202f: Offi J Int Acad Clin Appl Thromb\/Hemost. 2023;29:10760296231216966.","journal-title":"Clin Appl Thromb\/Hemost : Offi J Int Acad Clin Appl Thromb\/Hemost"},{"issue":"10","key":"1646_CR14","doi-asserted-by":"publisher","first-page":"2967","DOI":"10.1182\/bloodadvances.2021006484","volume":"6","author":"TF Overvad","year":"2022","unstructured":"Overvad TF, Ording AG, Nielsen PB, Skj\u00f8th F, Albertsen IE, Noble S, et al. Validation of the Khorana score for predicting venous thromboembolism in 40 218 patients with cancer initiating chemotherapy. Blood Adv. 2022;6(10):2967\u201376.","journal-title":"Blood Adv"},{"key":"1646_CR15","doi-asserted-by":"publisher","first-page":"101156","DOI":"10.1016\/j.gore.2023.101156","volume":"46","author":"RN Piver","year":"2023","unstructured":"Piver RN, Wagner VM, Levine MD, Backes FJ, Chambers LJ, Cohn DE, et al. Use of the Khorana score to predict venous thromboembolism in patients undergoing chemotherapy for uterine cancer. Gynecol Oncol Rep. 2023;46:101156.","journal-title":"Gynecol Oncol Rep"},{"key":"1646_CR16","doi-asserted-by":"publisher","DOI":"10.1177\/00033197231213197","author":"Y Qin","year":"2023","unstructured":"Qin Y, Liang X, Wu H, Sun X, Yan S, Wang N, et al. Development and validation of a modified khorana score for predicting venous thromboembolism in newly diagnosed stage IV lung cancer. Angiology. 2023. https:\/\/doi.org\/10.1177\/00033197231213197.","journal-title":"Angiology."},{"key":"1646_CR17","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/bs.acc.2023.02.006","volume":"114","author":"L Wauthier","year":"2023","unstructured":"Wauthier L, Favresse J, Hardy M, Douxfils J, Le Gal G, Roy PM, et al. D-dimer testing: a narrative review. Adv Clin Chem. 2023;114:151\u2013223.","journal-title":"Adv Clin Chem"},{"issue":"10","key":"1646_CR18","doi-asserted-by":"publisher","first-page":"2173","DOI":"10.1111\/jth.15813","volume":"20","author":"BG T\u00f8ndel","year":"2022","unstructured":"T\u00f8ndel BG, Morelli VM, Hansen JB, Braekkan SK. Risk factors and predictors for venous thromboembolism in people with ischemic stroke: a systematic review. J Thromb Haemost\u202f: JTH. 2022;20(10):2173\u201386.","journal-title":"J Thromb Haemost : JTH"},{"key":"1646_CR19","doi-asserted-by":"publisher","first-page":"107602962210955","DOI":"10.1177\/10760296221095558","volume":"28","author":"Y Wang","year":"2022","unstructured":"Wang Y, Zhou H, Zhong G, Fu Z, Peng Y, Yao T. Development and validation of a nomogram to predict the probability of venous thromboembolism in patients with epithelial ovarian cancer. Clin Appl Thromb\/Hemost\u202f: Offi J Int Acad Clin Appl Thromb\/Hemost. 2022;28:10760296221095558.","journal-title":"Clin Appl Thromb\/Hemost : Offi J Int Acad Clin Appl Thromb\/Hemost"},{"issue":"1","key":"1646_CR20","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1111\/j.1749-6632.2001.tb03544.x","volume":"936","author":"GDO Lowe","year":"2001","unstructured":"Lowe GDO, Rumley ANN. Fibrinogen and its degradation products as thrombotic risk factors. Ann N Y Acad Sci. 2001;936(1):560\u20135.","journal-title":"Ann N Y Acad Sci"},{"issue":"1","key":"1646_CR21","doi-asserted-by":"publisher","first-page":"928","DOI":"10.1186\/s13018-023-04407-y","volume":"18","author":"Y Jiao","year":"2023","unstructured":"Jiao Y, Mu X. Coagulation parameters correlate to venous thromboembolism occurrence during the perioperative period in patients with spinal fractures. J Orthop Surg Res. 2023;18(1):928.","journal-title":"J Orthop Surg Res"},{"issue":"1","key":"1646_CR22","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1001\/jamasurg.2013.3172","volume":"149","author":"VQ Trinh","year":"2014","unstructured":"Trinh VQ, Karakiewicz PI, Sammon J, Sun M, Sukumar S, Gervais M-K, et al. Venous thromboembolism after major cancer surgery: temporal trends and patterns of care. JAMA Surg. 2014;149(1):43\u20139.","journal-title":"JAMA Surg"},{"issue":"3","key":"1646_CR23","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1002\/rth2.12323","volume":"4","author":"SR Kahn","year":"2020","unstructured":"Kahn SR, Shivakumar S. What\u2019s new in VTE risk and prevention in orthopedic surgery. Res Pract Thromb Haemost. 2020;4(3):366\u201376.","journal-title":"Res Pract Thromb Haemost"},{"issue":"12","key":"1646_CR24","doi-asserted-by":"publisher","first-page":"3240","DOI":"10.1245\/s10434-011-1723-2","volume":"18","author":"J Hammond","year":"2011","unstructured":"Hammond J, Kozma C, Hart JC, Nigam S, Daskiran M, Paris A, et al. Rates of venous thromboembolism among patients with major surgery for cancer. Ann Surg Oncol. 2011;18(12):3240\u20137.","journal-title":"Ann Surg Oncol"},{"issue":"9","key":"1646_CR25","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1038\/nrneurol.2017.104","volume":"13","author":"SM Silvis","year":"2017","unstructured":"Silvis SM, de Sousa DA, Ferro JM, Coutinho JM. Cerebral venous thrombosis. Nat Rev Neurol. 2017;13(9):555\u201365.","journal-title":"Nat Rev Neurol"},{"issue":"1","key":"1646_CR26","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1186\/s12959-023-00526-y","volume":"21","author":"J Ding","year":"2023","unstructured":"Ding J, Yue X, Tian X, Liao Z, Meng R, Zou M. Association between inflammatory biomarkers and venous thromboembolism: a systematic review and meta-analysis. Thromb J. 2023;21(1):82.","journal-title":"Thromb J"},{"issue":"1","key":"1646_CR27","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1016\/j.jjcc.2019.06.013","volume":"75","author":"M Hiraide","year":"2020","unstructured":"Hiraide M, Shiga T, Minowa Y, Nakano Y, Yoshioka H, Suzuki K, et al. Identification of risk factors for venous thromboembolism and evaluation of Khorana venous thromboembolism risk assessment in Japanese lung cancer patients. J Cardiol. 2020;75(1):110\u20134.","journal-title":"J Cardiol"},{"key":"1646_CR28","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.thromres.2021.10.013","volume":"208","author":"J Li","year":"2021","unstructured":"Li J, Yi J, Hua L, Su Y, Huo M, Dou F, et al. Development and validation of a predictive score for venous thromboembolism in newly diagnosed non-small cell lung cancer. Thromb Res. 2021;208:45\u201351.","journal-title":"Thromb Res"},{"issue":"5","key":"1646_CR29","doi-asserted-by":"publisher","first-page":"168","DOI":"10.3892\/ol.2022.13288","volume":"23","author":"S Chlapoutakis","year":"2022","unstructured":"Chlapoutakis S, Georgakopoulou VE, Trakas N, Kouvelos G, Papalexis P, Damaskos C, et al. Characteristics and outcomes of cancer patients who develop pulmonary embolism: a cross-sectional study. Oncol Lett. 2022;23(5):168.","journal-title":"Oncol Lett"},{"key":"1646_CR30","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/j.thromres.2021.05.007","volume":"203","author":"S Goto","year":"2021","unstructured":"Goto S, Turpie AGG, Farjat AE, Weitz JI, Haas S, Ageno W, et al. The influence of anemia on clinical outcomes in venous thromboembolism: results from GARFIELD-VTE. Thromb Res. 2021;203:155\u201362.","journal-title":"Thromb Res"},{"key":"1646_CR31","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1016\/j.thromres.2019.12.011","volume":"186","author":"M Hultcrantz","year":"2020","unstructured":"Hultcrantz M, Modlitba A, Vasan SK, Sj\u00f6lander A, Rostgaard K, Landgren O, et al. Hemoglobin concentration and risk of arterial and venous thrombosis in 1.5 million Swedish and Danish blood donors. Thromb Res. 2020;186:86\u201392.","journal-title":"Thromb Res."},{"issue":"1","key":"1646_CR32","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1186\/s12957-022-02705-z","volume":"20","author":"R Mei","year":"2022","unstructured":"Mei R, Wang G, Chen R, Wang H. The ICU-venous thromboembolism score and tumor grade can predict inhospital venous thromboembolism occurrence in critical patients with tumors. World J Surg Oncol. 2022;20(1):245.","journal-title":"World J Surg Oncol"}],"container-title":["Breast Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12282-024-01646-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12282-024-01646-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12282-024-01646-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,9]],"date-time":"2025-01-09T11:16:00Z","timestamp":1736421360000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12282-024-01646-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,16]]},"references-count":32,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,1]]}},"alternative-id":["1646"],"URL":"https:\/\/doi.org\/10.1007\/s12282-024-01646-7","relation":{},"ISSN":["1340-6868","1880-4233"],"issn-type":[{"type":"print","value":"1340-6868"},{"type":"electronic","value":"1880-4233"}],"subject":[],"published":{"date-parts":[[2024,11,16]]},"assertion":[{"value":"29 July 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 October 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 November 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors have no known competing financial interests or personal affiliations that could impact this study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This study conformed to the principles of the Declaration of Helsinki for medical research involving human subjects. Informed consent was obtained from each patient in the study. The study protocol was approved by the Ethics Committee at Chongqing University Cancer Hospital (Approval No. CZLS20233343-A).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval and consent to participate"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}]}}